heptapeptide comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Updated 2026-05-11. Numbers and descriptions here follow the published literature rather than marketing material.
Semax is a synthetic heptapeptide with the sequence Met-Glu-His-Phe-Pro-Gly-Pro. Its design combines the ACTH(4-7) core fragment with a C-terminal Pro-Gly-Pro extension, a modification intended to improve stability and prolong activity. The molecule is hydrophilic, carries no lipid chains or glycosylation, and has a theoretical mass just over 810 daltons in its free form. All seven residues are proteinogenic amino acids, so no non-natural building blocks appear in the backbone. A free N-terminal methionine and C-terminal proline define the unmodified parent peptide.
The compound was developed during the 1980s at the Institute of Molecular Genetics in Moscow as part of research on fragments of adrenocorticotropic hormone. Early work examined short ACTH-derived sequences that retained neurotrophic effects while lacking the endocrine activity of the full hormone. Semax entered clinical use in Russia during the 1990s, where it received registration for several neurological indications. Outside that region it remained primarily a laboratory research material rather than an approved therapeutic. English-language literature on it grew more slowly and frequently cited the original Russian studies.
Pharmacological accounts link semax to melanocortin signalling and to modulation of neurotrophic factor expression, particularly brain-derived neurotrophic factor and nerve growth factor. Much of this evidence comes from rodent studies using intranasal delivery, a route chosen because it allows peptides to reach the central nervous system with limited systemic exposure. Whether the same mechanisms operate in humans at comparable magnitude remains an open question. The precise receptor or receptors responsible for the reported behavioural and neuroprotective effects have not been conclusively identified.
Clinical reports describe use in ischaemic stroke, transient ischaemic attack, optic nerve conditions, and cognitive complaints, but most of these studies are small and were conducted in a single region. Systematic reviews have generally described the evidence base as limited in size and variable in methodological quality. Randomised controlled data suitable for international regulatory assessment are scarce. As a result, major treatment guidelines outside Russia do not include the peptide, and interest in it remains largely research-driven rather than routine clinical.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic heptapeptide | ACTH(4-7) analogue |
| Sequence | Met-Glu-His-Phe-Pro-Gly-Pro | Free N terminus, unmodified side chains |
| Molecular weight | 813.9 Da | Free base; salt forms differ |
| Appearance | White to off-white powder | Lyophilised solid |
| Solubility | Freely soluble in water | Hydrophilic; polar solvents preferred |
Regulatory status varies sharply by country. Semax is registered for medical use in Russia, where it appears in formularies as a nasal solution, and it also holds registration in a small number of neighbouring states. It has no approval from the United States Food and Drug Administration or the European Medicines Agency, and it is not a scheduled controlled substance in most jurisdictions. Elsewhere it circulates mainly as laboratory material, so purity documentation comes from suppliers rather than from a national pharmacopoeia.
Semax is a synthetic peptide created in the Soviet Union during the early 1980s by researchers working in Moscow. It was built from the short adrenocorticotropic hormone fragment known as ACTH(4-10), and the chain was then extended with three additional amino acids. The resulting molecule was named semax and entered clinical use in Russia in 1994. It is generally described as a nootropic and neuroprotective agent rather than as a hormone analogue.
The parent fragment ACTH(4-10) carries the sequence Met-Glu-His-Phe-Arg-Trp-Gly. Semax replaces the arginine and tryptophan positions with a proline-glycine-proline tail, giving Met-Glu-His-Phe-Pro-Gly-Pro. That change removes residues associated with adrenal stimulation, so the peptide does not drive cortisol release the way full ACTH does. This distinction shapes how the compound is grouped in the literature, where it sits with neuropeptides and peptide neuromodulators rather than with corticosteroids.
Laboratory work points toward modulation of neurotrophic signaling, particularly expression of brain-derived neurotrophic factor and nerve growth factor in hippocampal tissue. Studies also describe effects on monoamine turnover, inflammatory mediators, and oxidative markers. These observations come mainly from animal models and cultured cells, so the causal chain in humans is not firmly established. Whether the reported molecular changes translate into measurable clinical benefit is an open question. Reviews generally present the mechanism as plausible rather than demonstrated.
Clinical evidence consists largely of small trials with modest sample sizes, often without independent replication. Reported endpoints include cognitive scores, recovery after stroke, and visual function, but study designs vary widely and few trials meet contemporary reporting standards. Systematic reviewers have noted a high risk of bias in several of these reports. No large multicenter trial conducted outside Russia has been published. The compound is therefore best described as investigational in most jurisdictions, with its clinical role still unresolved.
7 and Transitional Provisions) Order 1993 (S.I. 1993/2229) National Assistance (Assessment of Resources) (Amendment No.2) Regulations 1993 (S.I. 1993/2230) National Curriculum Council and School Examinations and Assessment Council (Designation of Staff) Order 1993 (S.I. 1993/2231) Export of Goods (Control) (Haiti) (Revocation) Order 1993 (S.I. 1993/2232) Motor Vehicles (Competitions and Trials) (Amendment) Regulations 1993 (S.I. 1993/2233) Road Traffic (Special Parking Areas) (London Boroughs of Bromley, Hammersmith and Fulham and Lewisham) (London Borough of Wandsworth) (Amendment) Order 1993 (S.I. 1993/2237) Housing (Extension of Right to Buy) Order 1993 (S.I. 1993/2240) Housing (Preservation of Right to Buy) Regulations 1993 (S.I. 1993/2241) Valuation Timetable (Scotland) Amendment (No.3) Order 1993 (S.I. 1993/2242) Housing (Right to Buy Delay Procedure) (Prescribed Forms) (Amendment) Regulations 1993 (S.I. 1993/2245) Housing (Right to Buy) (Prescribed Forms) (Amendment) Regulations 1993 (S.I. 1993/2246) Law Reform (Miscellaneous Provisions) (Scotland) Act 1990 (Commencement No.12) Order 1993 (S.I. 1993/2253) Public Trusts (Reorganisation) (Scotland) (No.2) Regulations 1993 (S.I. 1993/2254) Fish Health (Amendment) Regulations 1993 (S.I. 1993/2255) Royal National Hospital for Rheumatic Diseases National Health Service Trust (Transfer of Trust Property) Order 1993 (S.I. 1993/2256) St Peter's Hospital National Health Service Trust (Transfer of Trust Property) Order 1993 (S.I.
== Taxonomy == Amanita virosa was first described in 1838 by Swedish mycologist Elias Magnus Fries as Agaricus virosus, but this name is illegitimate since it had already been used for an earlier and different species. Amanita virosa was legitimately published by French mycologist Louis-Adolphe Bertillon in 1866.
=== RNA sequences can be edited within cells === Messenger RNA precursors from a wide range of organisms can be edited before being translated into protein. In this process, non-encoded nucleotides may be inserted into specific sites in the RNA, and encoded nucleotides may be removed or replaced. RNA editing was first discovered within the mitochondria of kinetoplastid protozoans, where it has been shown to be extensive. For example, some protein-coding genes encode fewer than 50% of the nucleotides found within the mature, translated mRNA. Other RNA editing events are found in mammals, plants, bacteria and viruses. These latter editing events involve fewer nucleotide modifications, insertions and deletions than the events within kinetoplast DNA, but still have high biological significance for gene expression and its regulation.
The young Appalachians reached elevations similar to today's Alps and Rockies—both of which are significantly younger mountain ranges—before 240 million years of natural erosion by water, wind, ice, and gravity gradually morphed them into the lower, rugged peaks typically seen today. Considering their extensive length, the Appalachians contain a diverse selection of biomes ranging from the temperate broadleaf and mixed Appalachian-Blue Ridge forest in the south to the boreal Eastern Canadian forest in the north. Conifers like red spruce and balsam fir dominate the north and high elevations, while deciduous trees like sugar maple and beech are more prevalent further south and oak-chestnut forests reign between. The climate ranges from humid subtropical to subarctic, with a few peaks in the Presidential Range of New Hampshire's White Mountains having a true tundra climate; many locations are also oceanic or humid continental. Mammals like black bear, white-tailed deer, squirrels, raccoons, and skunks are common throughout the range, while others like moose are more regionally limited. Birds, fish, shellfish, amphibians like salamanders, and other invertebrates are also abound in the profoundly ecologically diverse region. Once-largely extirpated species like the bobcat and coyote have also made a resurgence in recent years. The Appalachian Mountains are a barrier to east–west travel, as they form a series of alternating ridgelines and valleys oriented in opposition to most highways and railroads running east–west.
Sources: en.wikipedia.org
However, others have pointed out that C-peptides are produced in hypoglycaemic attacks caused by insulin produced naturally in the body, and these were not detected in any of the blood tests of the victims, indicating that the insulin had been introduced to their bodies externally and artificially. Norris lost an appeal against his conviction in 2009. In February 2021, the Criminal Cases Review Commission referred the case back to the Court of Appeal; this second appeal, heard in 2025, was also unsuccessful. Norris is believed to have been inspired by Jessie McTavish, a fellow Scottish nurse who was convicted of murdering a patient with insulin in 1974 before having her conviction quashed in 1975. The incident had happened at Ruchill Hospital in Glasgow, less than a mile from where Norris grew up. Shortly before he registered as a nurse, he had learned about McTavish.
After Commodore Perry opened up trade with Japan in 1854, Japanese green tea became the bulk of America’s tea imports. The 19th century saw the rise of iced tea, especially in the South. One of the earliest recipes for American iced tea appeared in Housekeeping in Old Virginia, a cookbook from 1879. It stated: “After scalding the teapot, put into it one quart of boiling water and two teaspoonfuls of green tea. ... Fill the goblets with ice and sugar. A squeeze of lemon will make this delicious and healthful, as it will correct the astringent tendency.” Alcoholic iced tea punches with cream, sugar, and liquor also became popular in the 19th century, especially in southern towns like Charleston and Savannah. These iced tea drinks resemble the modern Sweet bourbon punch and Long Island iced tea. Fish house punch was often also diluted with tea. The 19th century also saw the growth of various tea companies, like The Great American Tea Company, later renamed The Great Atlantic & Pacific (A&P) and the Oriental & Occidental Tea Company. During the hot days of the 1904 World's Fair in St. Louis, iced tea became the most popular drink at the fair among its 20 million visitors. This was a major moment in the rise in popularity of American iced tea. Prohibition (1920–1933) saw the rise of non-alcoholic iced teas, as clubs, hotels and other venues sought to re-stock their drink menus with other strong flavorful drinks. The introduction of the home refrigerator (1920s and '30s) also made it much easier for iced tea to be made at home.
=== Other features === All versions of ColdFusion prior to 6.0 were written using Microsoft Visual C++. This meant that ColdFusion was largely limited to running on Microsoft Windows, although Allaire did successfully port ColdFusion to Sun Solaris starting with version 3.1. The Allaire company was sold to Macromedia, then Macromedia was sold to Adobe. Earlier versions were not as robust as the versions available from version 4.0 forward. With the release of ColdFusion MX 6.0, the engine had been re-written in Java and supported its own runtime environment, which was easily replaced through its configuration options with the runtime environment from Sun. Version 6.1 included the ability to code and debug Macromedia Flash.
=== Unfolding and translocation === After a protein has been ubiquitinated, it is recognized by the 19S regulatory particle in an ATP-dependent binding step. The substrate protein must then enter the interior of the 20S subunit to come in contact with the proteolytic active sites. Because the 20S particle's central channel is narrow and gated by the N-terminal tails of the α ring subunits, the substrates must be at least partially unfolded before they enter the core. The passage of the unfolded substrate into the core is called translocation and necessarily occurs after deubiquitination. For an idealized substrate, translocation drives deubiquitination. However, the order in which substrates are deubiquitinated and unfolded is not yet clear. Which of these processes is the rate-limiting step in the overall proteolysis reaction depends on the specific substrate; for some proteins, the unfolding process is rate-limiting, while deubiquitination is the slowest step for other proteins. The extent to which substrates must be unfolded before translocation is suggested to be around 20 amino acid residues by the atomic structure of the substrate-engaged 26S proteasome in the deubiquitylation-compatible state, but substantial tertiary structure, and in particular nonlocal interactions such as disulfide bonds, are sufficient to inhibit degradation. The presence of intrinsically disordered protein segments of sufficient size, either at the protein terminus or internally, has also been proposed to facilitate efficient initiation of degradation.
An injection port is a medical device used for the administration of insulin or other physician-approved medicine into the subcutaneous tissue (the tissue layer just below the skin). The device is similar to infusion sets used by insulin pumps, except it is configured to receive a syringe instead of a tubing system. An injection port is usually a disposable device applied by the patient and worn for period of 3–5 days. When giving shots via an injection port, the needle stays above the surface of the skin Medication is delivered via a short soft cannula. An injection port can be used in conjunction with multiple daily injections of insulin by people with diabetes. It can also be used for the subcutaneous administration of any other physician prescribed medication.
Sources: en.wikipedia.org
It is a synthetic seven-amino-acid peptide built from the ACTH(4-7) sequence plus a Pro-Gly-Pro tail. It belongs to the family of short ACTH fragments studied for nervous-system effects. Its backbone contains only standard amino acids.
It contains the 4-7 fragment of adrenocorticotropic hormone extended at the C terminus. That truncation removes the region associated with steroidogenic activity. The design intent was to keep neurotrophic properties while avoiding full hormonal effects.
No natural source of the intact heptapeptide is known. It is produced by solid-phase peptide synthesis. Some related ACTH fragments arise as hormone processing products, but the Pro-Gly-Pro extension is a designed addition rather than a natural sequence.
It is described as a synthetic analogue of the ACTH(4–10) fragment, a short segment of adrenocorticotropic hormone. Its sequence differs from that fragment and includes two proline residues, which influence stability and behaviour in solution.